These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


340 related items for PubMed ID: 12832668

  • 21. Phosphodiesterase 4 inhibitor cilomilast inhibits fibroblast-mediated collagen gel degradation induced by tumor necrosis factor-alpha and neutrophil elastase.
    Kohyama T, Liu X, Zhu YK, Wen FQ, Wang HJ, Fang Q, Kobayashi T, Rennard SI.
    Am J Respir Cell Mol Biol; 2002 Oct; 27(4):487-94. PubMed ID: 12356583
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. IL-17A induces chromatin remodeling promoting IL-8 release in bronchial epithelial cells: Effect of Tiotropium.
    Anzalone G, Gagliardo R, Bucchieri F, Albano GD, Siena L, Montalbano AM, Bonanno A, Riccobono L, Pieper MP, Gjomarkaj M, Profita M.
    Life Sci; 2016 May 01; 152():107-16. PubMed ID: 27038884
    [Abstract] [Full Text] [Related]

  • 25. Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study.
    Compton CH, Gubb J, Nieman R, Edelson J, Amit O, Bakst A, Ayres JG, Creemers JP, Schultze-Werninghaus G, Brambilla C, Barnes NC, International Study Group.
    Lancet; 2001 Jul 28; 358(9278):265-70. PubMed ID: 11498212
    [Abstract] [Full Text] [Related]

  • 26. A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-alpha.
    Laan M, Prause O, Miyamoto M, Sjöstrand M, Hytönen AM, Kaneko T, Lötvall J, Lindén A.
    Eur Respir J; 2003 Mar 28; 21(3):387-93. PubMed ID: 12661990
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Fenofibrate Attenuates Neutrophilic Inflammation in Airway Epithelia: Potential Drug Repurposing for Cystic Fibrosis.
    Stolarz AJ, Farris RA, Wiley CA, O'Brien CE, Price ET.
    Clin Transl Sci; 2015 Dec 28; 8(6):696-701. PubMed ID: 26258991
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha.
    Cromwell O, Hamid Q, Corrigan CJ, Barkans J, Meng Q, Collins PD, Kay AB.
    Immunology; 1992 Nov 28; 77(3):330-7. PubMed ID: 1478679
    [Abstract] [Full Text] [Related]

  • 32. Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease.
    Knobloch J, Wahl C, Feldmann M, Jungck D, Strauch J, Stoelben E, Koch A.
    Basic Clin Pharmacol Toxicol; 2014 Feb 28; 114(2):202-9. PubMed ID: 23981542
    [Abstract] [Full Text] [Related]

  • 33. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4.
    Beeh KM, Kornmann O, Buhl R, Culpitt SV, Giembycz MA, Barnes PJ.
    Chest; 2003 Apr 28; 123(4):1240-7. PubMed ID: 12684317
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. IL-17A synergistically stimulates TNF-α-induced IL-8 production in human airway epithelial cells: A potential role in amplifying airway inflammation.
    Honda K, Wada H, Nakamura M, Nakamoto K, Inui T, Sada M, Koide T, Takata S, Yokoyama T, Saraya T, Kurai D, Ishii H, Goto H, Takizawa H.
    Exp Lung Res; 2016 May 28; 42(4):205-16. PubMed ID: 27269887
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors.
    Wollin L, Bundschuh DS, Wohlsen A, Marx D, Beume R.
    Pulm Pharmacol Ther; 2006 May 28; 19(5):343-52. PubMed ID: 16257550
    [Abstract] [Full Text] [Related]

  • 39. Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD.
    Milara J, Peiró T, Serrano A, Guijarro R, Zaragozá C, Tenor H, Cortijo J.
    Pulm Pharmacol Ther; 2014 Aug 28; 28(2):138-48. PubMed ID: 24525294
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.